# Extended Oral Tranexamic Acid After Total Knee Arthroplasty

> **NCT06618820** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Campbell Clinic** · enrollment: 120 (estimated)

## Conditions studied

- Osteo Arthritis Knee
- Pain, Postoperative

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06618820
- **Lead sponsor:** Campbell Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-17
- **Primary completion:** 2025-12
- **Final completion:** 2026-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06618820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06618820, "Extended Oral Tranexamic Acid After Total Knee Arthroplasty". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06618820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*